Lawmakers, Stakeholders Debate Solutions To Ease Off-Label Restrictions

Stakeholders and lawmakers debated whether legislation is needed to allow medical product manufacturers to communicate off-label information to physicians, payers and researchers during an Energy & Commerce health subcommittee hearing Wednesday (July 12). Participants disagreed on whether the two bills up for discussion -- both of which would allow for manufacturers to communicate off-label information with payers and physicians -- would give manufacturers more leeway to promote their products before FDA deems them officially safe and effective. However, most agreed...